Spatial transcriptome atlas reveals pulmonary microstructure-specific COVID-19 gene signatures in cynomolgus macaques

[1]  M. Ranjbar,et al.  Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table , 2022, International Immunopharmacology.

[2]  Lisa E. Gralinski,et al.  SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice , 2022, Science Translational Medicine.

[3]  E. López-Collazo,et al.  Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation , 2022, Biomolecules.

[4]  B. G. Hale,et al.  Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense , 2022, Cell Reports.

[5]  Amanda M. Saravia-Butler,et al.  System-wide transcriptome damage and tissue identity loss in COVID-19 patients , 2022, Cell Reports Medicine.

[6]  Chin Wee Tan,et al.  IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study , 2021, Frontiers in Immunology.

[7]  Dong Ho Kim,et al.  Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage , 2021, The Journal of infectious diseases.

[8]  Xuetao Cao.  ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection , 2021, Nature Immunology.

[9]  C. Ziegler,et al.  Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 , 2021, Cell.

[10]  Timothy L. Tickle,et al.  COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.

[11]  James Ziai,et al.  Clinical and research applications of multiplexed immunohistochemistry and in situ hybridization , 2021, The Journal of pathology.

[12]  C. Wouters,et al.  Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019 , 2021, Clinical & translational immunology.

[13]  K. To,et al.  Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic , 2021, Emerging microbes & infections.

[14]  Linda T. Nieman,et al.  Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection , 2020, Nature Communications.

[15]  Chin Wee Tan,et al.  Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures , 2020, European Respiratory Journal.

[16]  André F. Rendeiro,et al.  The spatial landscape of lung pathology during COVID-19 progression , 2021, Nature.

[17]  P. Sorger,et al.  Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques , 2020, Cell.

[18]  S. Farhadian,et al.  Sex differences in immune responses that underlie COVID-19 disease outcomes , 2020, Nature.

[19]  S. Serrano-Villar,et al.  Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients , 2020, Clinical Immunology.

[20]  Youngjeon Lee,et al.  Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2–Infected Macaques , 2020, The Journal of infectious diseases.

[21]  Yuxiao Song,et al.  Clinical characteristics of 82 cases of death from COVID-19 , 2020, PloS one.

[22]  A. Sette,et al.  Pre-existing immunity to SARS-CoV-2: the knowns and unknowns , 2020, Nature Reviews Immunology.

[23]  J. van Paassen,et al.  A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression , 2020, Modern Pathology.

[24]  D. Ye,et al.  Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19 , 2020, Trends in Pharmacological Sciences.

[25]  Christopher Earl,et al.  Preexisting and de novo humoral immunity to SARS-CoV-2 in humans , 2020, Science.

[26]  L. Delgado-Roche,et al.  Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.

[27]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[28]  M. Kasahara,et al.  The immunoproteasome and thymoproteasome: functions, evolution and human disease , 2018, Nature Immunology.

[29]  M. Okabe,et al.  DDX60 Is Involved in RIG-I-Dependent and Independent Antiviral Responses, and Its Function Is Attenuated by Virus-Induced EGFR Activation. , 2015, Cell reports.

[30]  J. Epstein,et al.  Plasticity of Hopx+ Type I alveolar cells to regenerate Type II cells in the lung , 2015, Nature Communications.

[31]  P. Svenningsson,et al.  S100A10 regulates plasminogen-dependent macrophage invasion. , 2010, Blood.

[32]  A. Xu,et al.  Upregulation of Mitochondrial Gene Expression in PBMC from Convalescent SARS Patients , 2006, Journal of Clinical Immunology.

[33]  D. Middleton,et al.  Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.

[34]  E. Prochownik,et al.  Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1 , 2005, Oncogene.